4-amino-1,8-Naphthalimide

CAS No. 1742-95-6

4-amino-1,8-Naphthalimide( —— )

Catalog No. M22109 CAS No. 1742-95-6

4-amino-1,8-Naphthalimide (4-ANI) is a PARP inhibitor with IC50 of 180 nM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 28 In Stock
25MG 50 In Stock
50MG 82 In Stock
100MG 133 In Stock
200MG 197 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    4-amino-1,8-Naphthalimide
  • Note
    Research use only, not for human use.
  • Brief Description
    4-amino-1,8-Naphthalimide (4-ANI) is a PARP inhibitor with IC50 of 180 nM.
  • Description
    4-amino-1,8-Naphthalimide (4-ANI) is a PARP inhibitor with IC50 of 180 nM.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Cell Cycle/DNA Damage
  • Target
    PARP
  • Recptor
    PARP
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1742-95-6
  • Formula Weight
    212.2
  • Molecular Formula
    C12H8N2O2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    Nc1ccc2C(=O)NC(=O)c3cccc1c23
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.SCHLICKER, A. 4-Amino-1,8-naphthalimide: a novel inhibitor of poly(ADP-ribose) polymerase and radiation sensitizer[J]. International Journal of Radiation Biology, 1999, 75(1):91-100.
molnova catalog
related products
  • SRI-011381

    SRI-011381, a new-type agonist of the TGF-beta signaling pathway, is utilized in the treatment of Alzheimer's disease.

  • E7449

    E7449 (2X-121) is a potent, orally bioavailable, brain penetrable dual inhibitor of PARP1/2 and TNKS1/2 with IC50 of 2.0/1.0 nM (PARP1/2), 50-100 nM (TNKS1/2).

  • ARTD10/PARP10-IN-1

    ARTD10/PARP10-IN-1 is a potent PARP inhibitor of the mono-ADP ribosyltransferases ARTD7/PARP15, ARTD8/PARP14, ARTD10/PARP10 and poly ADP-ribose polymerase-1 (ARTD1/PARP1), with potential anticancer and antitumour activity for the study of prostate and breast cancers.